Global Rheumatoid Arthritis Diagnostic Devices Market 2019-2023
Global Rheumatoid Arthritis Diagnostic Devices Market: About this market
Rheumatoid arthritis diagnostic devices are used to generate and modify sounds of various musical instruments electronically. Technavio’s rheumatoid arthritis diagnostic devices market analysis considers sales from both digital synthesizers and analog synthesizers segments, through retail and online stores. Our analysis also considers the sales of rheumatoid arthritis diagnostic devices in Asia, Europe, North America, and ROW. In 2018, the analyzers segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as enhanced productivity, emerging automated analyzers, and rising promotional activities for products will significantly help the market segment in maintaining its leading position. Also, our global rheumatoid arthritis diagnostic devices report has observed market growth factors such as the increasing number of rheumatoid arthritis cases, product launches, and a growing number of M&A in the value chain. However, high costs associated with rheumatoid arthritis diagnosis, product recalls, and difficulties and concerns related to rheumatoid arthritis diagnosis may hamper the growth of the rheumatoid arthritis diagnostic devices industry over the forecast period.
Global Rheumatoid Arthritis Diagnostic Devices Market: Overview
Increasing number of rheumatoid arthritis cases
The rising incidence of rheumatoid arthritis has encouraged various governments, vendors, and healthcare organizations in organizing programs on awareness about the condition and the treatment. As a result, the demand for diagnostic services for rheumatoid arthritis is increasing. Consequently, sales of rheumatoid arthritis diagnostic devices are rising. Therefore, this driver will contribute to the growth of the global rheumatoid arthritis diagnostic devices market at a CAGR of almost 6% during the forecast period.
Growing focus on biomarkers and precision medicine
Biomarkers have gained significance in treating rheumatoid arthritis as it can provide information about the progress of the condition. Furthermore, they can assist clinicians in assessing the probability of treatment response of patients, which will help them in administering precision medicines. As a result, vendors are focusing on applying biomarkers in their product offerings for an accurate diagnosis. Therefore, this trend will have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global rheumatoid arthritis diagnostic devices market during the forecast period 2019-2023, click here.
With the presence of several major players, the global rheumatoid arthritis diagnostic devices market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading rheumatoid arthritis diagnostic devices manufacturers, which include Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
Also, the rheumatoid arthritis diagnostic devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook